论文部分内容阅读
目的:探讨B型脑钠肽在老年患者支气管哮喘急性发作与心源性哮喘鉴别中的应用价值。方法:选取38例老年支气管哮喘急性发作期患者与35例心源性哮喘患者为对象,检测所有患者的B型脑钠肽水平,分析探讨两组患者动脉血氧分压、平均动脉压及心率之间的关系。结果:心源性哮喘患者急性发作期与控制期B型脑钠肽水平均明显高于支气管哮喘急性患者同期水平(P<0.05);支气管哮喘急性发作期患者PaO2、MAP及HR指标与心源性哮喘发作期患者指标有显著差异(P<0.05)。结论:加强B型脑钠肽指标检测可以提升老年患者支气管哮喘急性发作与心源性哮喘的鉴别率,该指标测定法操作简便、高效,值得临床推广应用。
Objective: To investigate the value of B-type natriuretic peptide in the differential diagnosis of acute asthma in elderly patients with asthma. Methods: Thirty-eight elderly patients with acute exacerbation of bronchial asthma and 35 patients with cardiogenic asthma were enrolled in this study. B-type natriuretic peptide levels were measured in all patients. The arterial partial pressure of oxygen, mean arterial pressure and heart rate The relationship between. Results: The levels of B-type natriuretic peptide and B-type natriuretic peptide in patients with acute asthma were significantly higher than those in patients with acute asthma (P <0.05). PaO2, MAP and HR in patients with acute exacerbation of bronchial asthma were significantly different There were significant differences in patients with asthma attack (P <0.05). Conclusion: The detection of B-type natriuretic peptide can enhance the discrimination between acute attack of bronchial asthma and cardiogenic asthma in elderly patients. The method is simple, effective and worthy of clinical application.